Abstract
Water soluble polymer, poly(vinyl pyrrolidone) was chosen to conjugate with 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(succinyl) (N-succinyl DPPE) to make a new drug delivery system. PVP with an amine group (amino-PVP) was polymerized by free radical polymerization. The amine group of amino-PVP was conjugated with the carboxylic group ofN-succinyl DPPE. The resultant conjugate could form nanoparticles in the aqueous solution; these nanoparticles were termed a lipid-polymer system. The critical aggregation concentration was measured with pyrene to give a value of 1 × 10−3 g/L. The particle size of the lipid-polymer system, as measured by DLS, AFM and TEM, was about 70 nm. Lipophilic component in the inner part of the lipid-polymer system could derive the physical interaction with hydrophobic drugs. Griseofulvin was used as a model drug in this study. The loading efficiency and release profile of the drug were measured by HPLC. The loading efficiency was about 54%. The release behavior was sustained for a prolonged time of 12 days. The proposed lipid-polymer system with biodegradable and biocompatible properties has promising potential as a passive-targeting drug delivery carrier because of its small particle size.
Similar content being viewed by others
References
V. S. Trubetskoy and V. P. Torchilin,Adv. Drug Deliv. Rev.,16, 331 (1995).
Z. Gao, A. N. Lukyanov, A. Singhal, and V. P. Torchilin,Nano Lett.,2, 979 (2002).
Z. Sezgin, N. Yüksel, and T. Baykara,Eur. J. Pharm. Biopharm.,64, 261 (2006).
M. Yokoyama, A. Satoh, Y. Sakurai, T. Okano, Y. Matsumura, T. Kakizoe, and K. Kataoka,J. Control. Relese,55, 2 (1998).
S. Y. Kim, I. G. Shin, M. Y. Lee, Y. K. Sung, T. Akaike, and C. S. Cho,J. Control. Relese,51, 13 (1998).
J. Wang, D. Mongayt, and V. P. Torchilin,J. Drug Target.,13, 73 (2005).
G. S. Kwon and T. Okano,Adv. Drug Deliv. Rev.,21, 107 (1996).
S. W. Hong, K. H. Kim, J. Huh, C. H. Ahn, and W. H. Jo,Macromol. Res.,13, 397 (2005).
S. V. Vinogradov, T. K. Bronich, and A. V. Kabanov,Bioconjugate Chem.,9, 805 (1998).
V. P. Torchilin,Eur. J. Pharm. Sci.,11, S81 (2000).
C. Washington,Adv. Drug Delv. Rev.,20, 131 (1996).
V. P. Torchilin, T. S. Levchenko, K. R. Whiteman, A. A. Yaroslavov, A. M. Tsatsakis, A. K. Rizos, E. V. Michailova, and M. I. Shtilman,Biomaterials,22, 3035 (2001).
A. K. Rizos, I. Tsikalas, A. M. Tsatsakis, and M. I. Shtilman,J. Non-Crystal Solids,352, 5055 (2006).
Y. P. Jung, Y. K. Son, and J. H. Kim,Macromol. Res.,15, 82 (2007).
A. Benahmed, M. Ranger, and J. C. Leroux,Pharm. Res.,18, 323 (2001).
Y. Mu, H. Kamada, H. Kodaira, K. Sato, Y. Tsutsumi, M. Maeda, K. Kawasaki, M. Nomizu, Y. Yamada, and T. Mayumi,Biochem. Biophys. Res. Comm.,264, 763 (1999).
A. J. M. D’Souza, R. L. Schowen, and E. M. Topp,J. Control. Relese,94, 91 (2004).
D. L. Garrec, S. Gori, L. Luo, D. Lessard, D. C. Smith, M.-A. Yessine, M. Ranger, and J.-C. Leroux,J. Control. Relese,99, 83 (2004).
R. J. Lee and P. S. Low,Biochim. Biophys. Acta,1233, 134 (1995).
E. Finkelstein, B. Amichai, and M. H. Grunwald,Int. J. Antimicrobial Agents,6, 189 (1996).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, H.Y., Yu, S.A., Jeong, K.H. et al. Poly(vinyl pyrrolidone) conjugated lipid system for the hydrophobic drug delivery. Macromol. Res. 15, 547–552 (2007). https://doi.org/10.1007/BF03218829
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03218829